Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 1
1991 1
1992 3
1993 1
1997 2
1998 3
1999 3
2000 3
2001 4
2002 5
2003 3
2004 3
2005 8
2006 2
2007 4
2008 8
2009 9
2010 12
2011 17
2012 17
2013 20
2014 17
2015 22
2016 31
2017 19
2018 30
2019 37
2020 31
2021 40
2022 38
2023 32
2024 26
2025 39
2026 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

410 results

Results by year

Filters applied: . Clear all
Page 1
Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.
Rammant E, Fox L, De Padova S, Liedberg F, Wintner LM, Holzner B, Aaronson NK, Beyer K, Bex A, Čapoun O, Catto JWF, Chaloner R, Costin M, Decaestecker K, Enting D, Fonteyne V, Hendricksen K, Kachel T, Kassianos A, Lewis R, Makaroff L, Morcom E, Neuzillet Y, O'Brien T, Pappot H, Philipps L, Richters A, Ripping DM, Rouanne M, Rudman S, Shrestha S, Soukup V, Spaas M, Sztankay M, Thomas C, van Leeuwen M, Van Hemelrijck M; EORTC Quality of Life Group. Rammant E, et al. Among authors: bex a. Eur Urol Oncol. 2026 May 26:S2588-9311(26)00125-2. doi: 10.1016/j.euo.2026.04.016. Online ahead of print. Eur Urol Oncol. 2026. PMID: 42191529 Free article.
Nephron Sparing Treatment (NEST) for small renal masses: understanding patients' and clinicians' experiences of a cohort-embedded randomised control trial.
Ranieri V, Warren H, Neves JB, Santiapillai J, Rode N, Cullen D, Munneke G, Walkden M, Patki P, Barod R, Mumtaz F, Aitchison M, Pizzo E, Williams NR, Wildgoose WH, Gurusamy K, Emberton M, Bex A, Tran MGB. Ranieri V, et al. Among authors: bex a. Pilot Feasibility Stud. 2026 May 13. doi: 10.1186/s40814-026-01833-7. Online ahead of print. Pilot Feasibility Stud. 2026. PMID: 42121227 Free article.
Management of Lymph Node-Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.
Capitanio U, Zondervan P, Campi R, Kuusk T, Klatte T, Abu-Ghanem Y, Bonn S, Breen DJ, Dabestani S, Hora M, Lund L, Marconi L, Palumbo C, Pignot G, Tran M, Woodward R, Suárez C, Powles T, Bedke J, Bex A. Capitanio U, et al. Among authors: bex a. Eur Urol. 2026 May 12:S0302-2838(26)02092-0. doi: 10.1016/j.eururo.2026.04.001. Online ahead of print. Eur Urol. 2026. PMID: 42120219
Comprehensive Genomic and Transcriptomic Characterization of Matched Primary and Recurrent Tumors in High-risk Localized Renal Cell Carcinoma.
Xu W, Rini BI, Albiges L, Tang X, Koeppen H, Bex A, Suárez C, Uzzo R, Master V, Karam JA, Hamidi H, Assaf ZJ, Dubey S, Goluboff ET, Carter C, Banchereau R, Huseni MA, Pal SK. Xu W, et al. Among authors: bex a. Eur Urol. 2026 Apr 25:S0302-2838(26)02060-9. doi: 10.1016/j.eururo.2026.03.023. Online ahead of print. Eur Urol. 2026. PMID: 42036258
PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial.
Johnson D, Thomas R, Cotton S, Newlands R, Cooper D, McCann S, Vale L, Gillies K, Bex A, Challacombe B, Falloon J, MacLennan G, Narahari K, Nicol D, Sheerin N, Stewart GD, Tran M, Heer R, Soomro N. Johnson D, et al. Among authors: bex a. Trials. 2026 Mar 20;27(1):331. doi: 10.1186/s13063-026-09624-4. Trials. 2026. PMID: 41863008 Free PMC article.
Clinical outcomes of stereotactic MRI-guided adaptive radiotherapy for renal tumors in patients with a solitary kidney.
van Vliet C, Caro J, Bohoudi O, Bex A, Damhoff D, van den Eertwegh FJM, Graafland NM, Lagerveld BW, van Moorselaar JRA, Palacios MA, Tetar SU, Verheijen S, Weitkamp NW, van der Wel A, Zondervan PJ, Slotman BJ, Bruynzeel AME. van Vliet C, et al. Among authors: bex a. Radiother Oncol. 2026 Apr;217:111389. doi: 10.1016/j.radonc.2026.111389. Epub 2026 Jan 24. Radiother Oncol. 2026. PMID: 41587617 Free article.
410 results